Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-02-25 @ 9:48 PM
Study NCT ID:
NCT02852005
Status:
COMPLETED
Last Update Posted:
2022-08-08
First Post:
2016-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-28
First Submit QC Date:
None
Study First Post Date:
2016-08-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-16
Results First Submit QC Date:
None
Results First Post Date:
2021-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-04
Last Update Post Date:
2022-08-08
Last Update Post Date Type:
ACTUAL